81 related articles for article (PubMed ID: 8608454)
1. Induction of tissue inhibitor of metalloproteinase and its mitogenic response to endothelial cells in human atherosclerotic and restenotic lesions.
Tyagi SC; Meyer L; Kumar S; Schmaltz RA; Reddy HK; Voelker DJ
Can J Cardiol; 1996 Apr; 12(4):353-62. PubMed ID: 8608454
[TBL] [Abstract][Full Text] [Related]
2. Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy.
Tyagi SC; Kumar SG; Haas SJ; Reddy HK; Voelker DJ; Hayden MR; Demmy TL; Schmaltz RA; Curtis JJ
J Mol Cell Cardiol; 1996 Jul; 28(7):1415-28. PubMed ID: 8841929
[TBL] [Abstract][Full Text] [Related]
3. Temporal expression of extracellular matrix metalloproteinases and tissue plasminogen activator in the development of collateral vessels in the canine model of coronary occlusion.
Tyagi SC; Kumar S; Cassatt S; Parker JL
Can J Physiol Pharmacol; 1996 Aug; 74(8):983-95. PubMed ID: 8960389
[TBL] [Abstract][Full Text] [Related]
4. Proteinases and restenosis in the human coronary artery: extracellular matrix production exceeds the expression of proteolytic activity.
Tyagi SC; Meyer L; Schmaltz RA; Reddy HK; Voelker DJ
Atherosclerosis; 1995 Jul; 116(1):43-57. PubMed ID: 7488332
[TBL] [Abstract][Full Text] [Related]
5. Integrin and matrix metalloproteinase expression in human carotid plaque.
Murillo CA; Woodside KJ; Guo Q; Zhang S; O'Connor KL; Hunter GC
J Surg Res; 2009 Jul; 155(1):157-64. PubMed ID: 19394653
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of extracellular matrix metalloproteinase and tissue inhibitor by heparin and cholesterol in fibroblast cells.
Tyagi SC; Kumar S; Katwa L
J Mol Cell Cardiol; 1997 Jan; 29(1):391-404. PubMed ID: 9040053
[TBL] [Abstract][Full Text] [Related]
7. Induction of tissue inhibitor and matrix metalloproteinase by serum in human heart-derived fibroblast and endomyocardial endothelial cells.
Tyagi SC; Kumar S; Glover G
J Cell Biochem; 1995 Jul; 58(3):360-71. PubMed ID: 7593257
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix regulation of metalloproteinase and antiproteinase in human heart fibroblast cells.
Tyagi SC; Kumar SG; Alla SR; Reddy HK; Voelker DJ; Janicki JS
J Cell Physiol; 1996 Apr; 167(1):137-47. PubMed ID: 8698831
[TBL] [Abstract][Full Text] [Related]
9. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
[TBL] [Abstract][Full Text] [Related]
10. Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells.
Tyagi SC; Lewis K; Pikes D; Marcello A; Mujumdar VS; Smiley LM; Moore CK
J Cell Physiol; 1998 Aug; 176(2):374-82. PubMed ID: 9648925
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema.
Ohnishi K; Takagi M; Kurokawa Y; Satomi S; Konttinen YT
Lab Invest; 1998 Sep; 78(9):1077-87. PubMed ID: 9759652
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion.
Stearns ME; Rhim J; Wang M
Clin Cancer Res; 1999 Jan; 5(1):189-96. PubMed ID: 9918218
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
14. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
15. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
Ottino P; He J; Axelrad TW; Bazan HE
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):487-96. PubMed ID: 15671273
[TBL] [Abstract][Full Text] [Related]
16. The effects of high glucose and atorvastatin on endothelial cell matrix production.
McGinn S; Poronnik P; Gallery ED; Pollock CA
Diabet Med; 2004 Oct; 21(10):1102-7. PubMed ID: 15384957
[TBL] [Abstract][Full Text] [Related]
17. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B
Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
[TBL] [Abstract][Full Text] [Related]
18. Expression of collagen, interstitial collagenase, and tissue inhibitor of metalloproteinases-1 in restenosis after carotid endarterectomy.
Nikkari ST; Geary RL; Hatsukami T; Ferguson M; Forough R; Alpers CE; Clowes AW
Am J Pathol; 1996 Mar; 148(3):777-83. PubMed ID: 8774133
[TBL] [Abstract][Full Text] [Related]
19. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.
Young-Min SA; Beeton C; Laughton R; Plumpton T; Bartram S; Murphy G; Black C; Cawston TE
Ann Rheum Dis; 2001 Sep; 60(9):846-51. PubMed ID: 11502611
[TBL] [Abstract][Full Text] [Related]
20. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]